GRAM NEGATIVES STUDY

ConditionMulti-resistant Gram-negative Bacteria Cause Infection

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorFundacion SEIMC-GESIDA

About this trial

This is a prospective, observational, multicenter study whose main objective is to develop a predictive model of mortality in critically ill patients colonized by multidrug-resistant Gram-negative bacteria (MDR-GNB).

Secondary objectives include: determining the characteristics of patients colonized by MRGB who require admission or acquire colonization during their stay in an intensive care unit (ICU); studying the infectious complications they develop, their etiology, clinical impact, and prognosis.

Eligibility criteria

Qualifiers

Patients aged ≥18 years

Have given informed consent.

Disqualifiers

Patients who do not agree to participate in the study

Admission to the ICU < 24 hours

Trial design

Treatments tested in this trial

Standard of care therapy

Treatment groups

1,500 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Fundacion SEIMC-GESIDA

Lead sponsor

Source ClinicalTrials.gov